Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPrimorus Inv. Regulatory News (PRIM)

Share Price Information for Primorus Inv. (PRIM)

Share Price is delayed by 15 minutes
Get Live Data
3.70    0.00 (0.00%)
Bid:
3.40
Ask:
4.00
Spread: 0.60 (17.647%)
Market Cap: £4.61m
PRIM Live PriceLast checked at - London Stock Exchange

Intraday Primorus Inv. Share Chart

Engage Technology Investor Update

7 Nov 2018 07:00

RNS Number : 5934G
Primorus Investments PLC
07 November 2018
 

Primorus Investments plc

("Primorus" or the "Company")

Engage Technology Investor Update Received

 

Primorus Investments plc (AIM: PRIM, NEX: PRIM) is pleased to provide shareholders with an update on its investment in the SaaS ("Software as a Service") end-to-end workforce software vendor Engage Technology Partners ("`Engage") by way of an update received by Primorus from Engage. Primorus has invested a total of GBP£1.4m in Engage made up of GBP£400,000 at £15 per share and GBP£1.0m at £22 per share.

 

This update follows on from information provided in the Primorus Q3 Report announced on 24 October 2018 and please note that some areas of content of the Engage Report is deemed commercial in confidence however Engage have kindly allowed us to transmit some of the information for the benefit of Primorus shareholders.

 

Highlights;

· Strong construction market penetration via VMS ("Vendor Management System") sales to Tier 1 construction companies. Post-period reporting 75 live Corporate Clients with a further 17 contracted pending going live.

 

· Significant corporate interest from global software vendors and aggregators in Engage products and the Engage platform. Discussions with multi-party potential corporate investors accelerate.

 

· Collaboration with California-based Jumio to incorporate and integrate their global RTW ("Right To Work") verification solution into the Engage platform.

 

· Completed several keenly awaited critical first version self-serve product units including OSP ("Outsourced Payroll Product") and PAYE for Temps allowing the entire platform to attain a level of self service across the offering.

 

· A product scaling refinement has reduced the run-rate average monthly revenues to below management forecasts. Pleasingly product engineering has already mitigated this specific issue.

 

· Projected platform revenues expected to accelerate into Q1 2019 and point of maximum product development spend reached in October and cashflows heading back towards breakeven in 2019.

Alastair Clayton, Executive Director, commented:

"We are pleased to report a summary of a very positive Quarterly Report received from Engage and I am happy to be able to share what I am allowed to with shareholders. It is clear the Engage team continue to win business at an impressive rate and what is noteworthy is the speed with which the Engage VMS product has penetrated the market. With several key self-service product deliveries dropping in the Quarter we are closely watching the platform's ability over the coming few quarters to automate the on-boarding process and generate globally scalable revenues from its existing and future customers.

We invested in Engage not because of its immediate revenue generation, and there was a (now mitigated) revenue miss this quarter as outlined above, but because we believe the viral nature of the platform has the potential to totally disrupt the existing software offerings servicing this huge global sector. What is most pleasing is that we have begun to see the first signs that the sales aspect of the Engage platform is both viral from the bottom of the supply chain upwards but also top down from large corporates seeking solutions for their UK and overseas operations.

I believe that, should the trajectory of client wins, and product delivery, continue to grow as they are, we will begin to see the revenue gain pace and grow exponentially over the coming quarter or two as all the benefits of taking the time (and money) to build a truly globally scalable, self-service, pure SaaS platform begin to pay off. Engage have taken a more difficult path to deliver a better revenue outcome.

As with many of the private businesses we meet, I see the biggest risk for Engage as one of executing small short-term financings in a market dominated by large, Private Equity and Venture Capital investors. Make no mistake, just because Engage needs modest amounts of money to execute its plan, it doesn't mean the resulting company cannot, in my opinion, be a global market force.

We are aware that whilst this strategy may not fit the standard large investors "cookie-cutter" investment criteria, it does fit ours. Judging by the significant corporate interest being shown in the Engage platform by other specialist investors, global HR software vendors and aggregators, I am confident that we are not alone."

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

For further information, please contact:

Primorus Investments plc:

+44 (0) 20 7440 0640

Alastair Clayton

Nominated Adviser:

+44 (0) 20 7213 0880

Cairn Financial Advisers LLP

James Caithie / Sandy Jamieson

Broker:

+44 (0) 20 3621 4120

Turner Pope Investments

Andy Thacker

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDLIFIRLSLDIIT
Date   Source Headline
2nd Jun 20269:35 amRNSFinal Results
24th Apr 20262:00 pmRNSDirector/PDMR Shareholding
7th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:00 amRNSFurther Investment in Fresho Pty Ltd
10th Feb 20267:00 amRNSBoard role changes
15th Jan 20264:38 pmRNSHolding(s) in Company
9th Jan 20267:00 amRNSTransaction in Own Shares & TR1
8th Jan 20267:00 amRNSTransaction in Own Shares
30th Dec 20257:00 amRNSTransaction in Own Shares
30th Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
18th Dec 20257:00 amRNSTransaction in Own Shares
29th Oct 20257:00 amRNSTransaction in Own Shares
20th Oct 20257:00 amRNSTransaction in Own Shares
9th Oct 20257:00 amRNSTransaction in Own Shares
2nd Oct 20257:00 amRNSTransaction in Own Shares
24th Sep 20257:00 amRNSInvestee Company Update - Virtualstock
23rd Sep 20257:00 amRNSHalf-year Report
20th Aug 20257:00 amRNSTransaction in Own Shares
6th Aug 20252:01 pmRNSHolding(s) in Company
6th Aug 20257:00 amRNSTransaction in Own Shares & TR-1
28th Jul 20257:00 amRNSTransaction in Own Shares
25th Jul 20257:00 amRNSHolding(s) in Company
24th Jul 20257:48 amRNSTransaction in Own Shares
18th Jul 20254:12 pmRNSHolding(s) in Company
17th Jul 20257:00 amRNSTransaction in Own Shares & TR-1
16th Jul 20257:00 amRNSTransaction in Own Shares
15th Jul 20257:00 amRNSTransaction in Own Shares
14th Jul 202512:30 pmRNSAnnouncement by Pri0r1ty Intelligence Group PLC
11th Jul 20258:03 amRNSTransaction in Own Shares
11th Jul 20257:00 amRNSHolding(s) in Company
10th Jul 20257:00 amRNSTransaction in Own Shares
9th Jul 20257:00 amRNSTransaction in Own Shares
8th Jul 20251:35 pmRNSResult of AGM
25th Jun 202510:05 amRNSHoldings in Company
25th Jun 20257:00 amRNSInvestee Company Update - Pri0r1ty
13th Jun 20257:00 amRNSNotice of AGM & Proposed Rule 9 Waiver
30th May 20254:25 pmRNSFinal Results
31st Mar 20257:00 amRNSFurther Investment in Interpac Ltd
20th Jan 202511:00 amRNSDirector/PDMR Shareholding
20th Jan 202511:00 amRNSHolding(s) in Company
23rd Dec 20242:10 pmRNSInvestee Company Update – Alteration Earth
5th Nov 20247:00 amRNSSale Of Engage Shareholding
23rd Oct 202412:10 pmRNSHolding(s) in Company
30th Sep 20247:00 amRNSHolding(s) in Company
27th Sep 20245:05 pmRNSDirector/PDMR Shareholding
20th Sep 20241:10 pmRNSFurther Investment - Replacement
20th Sep 20247:00 amRNSFurther Investment in Fresho Pty Ltd
5th Sep 20247:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.